Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LEONID SHUNYAKOV

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1396709895
CMS profile
335741
Location
BOLIVAR, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$334,003.60

455 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $44,772.25 44
AstraZeneca Pharmaceuticals LP $32,593.54 29
Seagen Inc. $31,001.83 34
Janssen Biotech, Inc. $29,957.21 25
GlaxoSmithKline, LLC. $29,108.80 20
JAZZ PHARMACEUTICALS INC. $25,013.52 22
Daiichi Sankyo Inc. $24,743.50 23
BeiGene USA, Inc. $23,858.35 23
GENZYME CORPORATION $20,670.85 18
Regeneron Healthcare Solutions, Inc. $15,071.11 13
Karyopharm Therapeutics Inc. $12,554.75 12
Genentech USA, Inc. $8,991.99 24
ABBVIE INC. $6,027.50 14
Roche Diagnostics Corporation $4,919.61 10
Genentech, Inc. $4,366.43 5
Celgene Corporation $4,279.42 28
Merck Sharp & Dohme LLC $3,862.98 10
Pharmacyclics LLC, an AbbVie Company $3,354.97 9
Lilly USA, LLC $2,921.99 2
Janssen Scientific Affairs, LLC $1,887.75 2
Exelixis Inc. $1,721.79 5
Epizyme, Inc., $487.16 3
Novartis Pharmaceuticals Corporation $255.74 15
PFIZER INC. $206.67 15
SANOFI-AVENTIS U.S. LLC $181.98 2
Gilead Sciences, Inc. $151.10 5
CTI BioPharma Corp. $117.42 1
Incyte Corporation $115.98 2
Amgen Inc. $98.19 1
Progenics Pharmaceuticals, Inc. $84.68 1
Rigel Pharmaceuticals, Inc. $61.24 4
Sun Pharmaceutical Industries Inc. $54.64 3
SERVIER PHARMACEUTICALS LLC $51.50 3
Foundation Medicine, Inc. $51.21 2
ARRAY BIOPHARMA INC $50.25 5
EISAI INC. $48.88 3
Kyowa Kirin, Inc. $41.87 2
Kite Pharma, Inc. $41.59 2
Verity Pharmaceuticals Inc. $29.16 2
Takeda Pharmaceuticals U.S.A., Inc. $27.78 2
Acrotech Biopharma LLC $25.90 2
Pharmacosmos Therapeutics Inc. $22.44 1
Organon LLC $21.15 1
Accord Healthcare, Inc. $20.87 1
PharmaEssentia USA Corporation $17.54 1
Myovant Sciences Inc. $16.16 1
G1 Therapeutics, Inc. $15.86 1
Sobi, Inc $14.23 1
EMD Serono, Inc. $12.27 1

Page 2 of 10; records 51–100 of 455 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LEONID SHUNYAKOV

NPI 1396709895 · CMS profile ID 335741

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

BOLIVAR, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 10; records 51–100 of 455 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396709895?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LEONID SHUNYAKOV, NPI 1396709895, CMS profile ID 335741. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 10; records 51–100 of 455 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396709895?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LEONID SHUNYAKOV, NPI 1396709895, CMS profile ID 335741. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 10; records 51–100 of 455 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396709895?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LEONID SHUNYAKOV, NPI 1396709895, CMS profile ID 335741, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 10; records 51–100 of 455 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1396709895?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

455 matching records · $334,003.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 455 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 455.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BeiGene USA, Inc. $53.4811/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940793011 CMS
BeiGene USA, Inc. $559.9611/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940793013 CMS
BeiGene USA, Inc. $101.8011/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940793015 CMS
BeiGene USA, Inc. $286.0611/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940793017 CMS
BeiGene USA, Inc. $307.9011/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940793019 CMS
Novartis Pharmaceuticals Corporation $15.1611/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894372243 CMS
Regeneron Healthcare Solutions, Inc. $1,096.0011/15/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927400271 CMS
Rigel Pharmaceuticals, Inc. $16.9811/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962263775 CMS
Seagen Inc. $21.8811/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113805 CMS
Seagen Inc. $1,262.6111/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113807 CMS
Seagen Inc. $3,815.0011/13/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113809 CMS
Seagen Inc. $604.7411/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113811 CMS
Seagen Inc. $865.7211/13/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113813 CMS
Seagen Inc. $106.9411/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904113815 CMS
Daiichi Sankyo Inc. $4,450.0011/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930862743 CMS
EISAI INC. $17.1111/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908057383 CMS
E.R. Squibb & Sons, L.L.C. $99.6411/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625449 CMS
E.R. Squibb & Sons, L.L.C. $4.8811/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625471 CMS
Janssen Biotech, Inc. $1,100.0011/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886073247 CMS
Sun Pharmaceutical Industries Inc. $26.7611/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947825835 CMS
ARRAY BIOPHARMA INC $10.7211/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949500265 CMS
ARRAY BIOPHARMA INC $0.6511/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949500267 CMS
AstraZeneca Pharmaceuticals LP $4,450.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914723493 CMS
Daiichi Sankyo Inc. $123.0311/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930866847 CMS
Regeneron Healthcare Solutions, Inc. $4,932.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927400263 CMS
Celgene Corporation $16.7611/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625427 CMS
AstraZeneca Pharmaceuticals LP $4,450.0011/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914712247 CMS
Regeneron Healthcare Solutions, Inc. $913.3311/04/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927400255 CMS
Celgene Corporation $16.1611/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625429 CMS
E.R. Squibb & Sons, L.L.C. $4,780.0011/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625439 CMS
AstraZeneca Pharmaceuticals LP $51.7411/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914633371 CMS
AstraZeneca Pharmaceuticals LP $288.7511/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914649271 CMS
Roche Diagnostics Corporation $2,724.0011/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950053555 CMS
Verity Pharmaceuticals Inc. $16.3511/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946800835 CMS
E.R. Squibb & Sons, L.L.C. $10.1910/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625465 CMS
Celgene Corporation $13.8710/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625461 CMS
Celgene Corporation $0.1810/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932625463 CMS
Regeneron Healthcare Solutions, Inc. $63.8710/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927400247 CMS
Genentech USA, Inc. $13.2210/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950747619 CMS
AstraZeneca Pharmaceuticals LP $397.5010/26/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914688319 CMS
AstraZeneca Pharmaceuticals LP $125.0010/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915014393 CMS
PFIZER INC. $11.3110/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949468327 CMS
GlaxoSmithKline, LLC. $15.2810/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944565883 CMS
Janssen Biotech, Inc. $2,200.0010/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886073235 CMS
Karyopharm Therapeutics Inc. $97.5010/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946522251 CMS
Karyopharm Therapeutics Inc. $69.1710/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946522257 CMS
Karyopharm Therapeutics Inc. $5,250.0010/25/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946522263 CMS
AstraZeneca Pharmaceuticals LP $4,450.0010/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915733219 CMS
Merck Sharp & Dohme LLC $325.0010/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944046807 CMS
Pharmacyclics LLC, an AbbVie Company $25.0010/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890347875 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $324,796.96 410
PY2020 $129,096.10 205
PY2021 $233,777.75 277
PY2022 $334,003.60 455
PY2023 $348,699.85 445
PY2024 $327,068.46 442
PY2025 $389,146.89 417

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,457.56 11
PY2024 Principal investigator $113,549.17 30
PY2023 Recipient $1,734.05 1
PY2023 Principal investigator $159,918.88 34
PY2022 Principal investigator $155,538.67 49
PY2021 Recipient $815.45 1
PY2021 Principal investigator $143,240.51 97
PY2020 Principal investigator $57,996.88 32
PY2019 Recipient $961.88 1
PY2019 Principal investigator $85,571.90 61

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $196.00 11/07/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737881
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $353.60 11/07/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737883
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,035.00 11/07/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737885
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,040.20 09/18/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
C16038 (SWITCH) An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Induction Regimen (US MM-6) No dispute reported 06/30/2026 1223285688
Principal investigator 1 Mirati Therapeutics, Inc. $5,246.16 07/08/2025 Non-covered Recipient Entity
Central Care Cancer Center
A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Ther No dispute reported 06/30/2026 1236531197
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $925.00 04/28/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737875
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $822.00 04/28/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737877
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $104.00 04/28/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737879
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $249.60 01/23/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737871
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $156.00 01/07/2025 Non-covered Recipient Entity
CENTRAL CARE CANCER CENTER
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233737873
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $330.00 01/03/2025 Non-covered Recipient Entity
Central Care Cancer Center
A Phase 3b randomized study of lenalidomide (CC-5013)plus rituximab maintenance therapy followed by lenalidomide singe-agent maintenance vs. rituximab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma No dispute reported 06/30/2026 1235998214